2018
DOI: 10.1093/ofid/ofy281
|View full text |Cite
|
Sign up to set email alerts
|

First Case of Diffuse Leishmaniasis Associated With Leishmania panamensis

Abstract: Leishmania panamensis is the most common species of Leishmania in Panama, and it is known to cause cutaneous leishmaniasis, disseminated cutaneous leishmaniasis, and mucocutaneous leishmaniasis; however, it not associated with diffuse cutaneous disease. In this study, we report the first case of diffuse cutaneous leishmaniasis caused by L panamensis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
8
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 13 publications
0
8
0
Order By: Relevance
“…panamensis has been associated to diverse cutaneous forms of the disease, a behavior that might be the result of local interplay between L. panamensis variants and human populations with different genetic backgrounds. (16,17,18,19) Little is known about the population structure of L. panamensis in Panama. Local studies focus mainly on discriminating Leishmania species on vectors, hosts, and humans rather than inferring their genetic diversity.…”
mentioning
confidence: 99%
“…panamensis has been associated to diverse cutaneous forms of the disease, a behavior that might be the result of local interplay between L. panamensis variants and human populations with different genetic backgrounds. (16,17,18,19) Little is known about the population structure of L. panamensis in Panama. Local studies focus mainly on discriminating Leishmania species on vectors, hosts, and humans rather than inferring their genetic diversity.…”
mentioning
confidence: 99%
“…4 The spectrum of cutaneous manifestations associated with CL in the New World includes ulcerative, diffuse, disseminated, and atypical forms (psoriasiform, verrucous, zosteriform, or nodular). 6,9 The Pan American Health Organization recommends assessing the annual CL transmission index to identify the locations within the Americas with the highest risk of transmission. Used to prioritize and control interventions, this index is constituted by the annual incidence of CL and the density of transmission which is defined as the total annual number of CL cases in a defined geographic area by municipalities, regions, and subregions of countries with existing leishmaniasis transmission.…”
Section: Discussionmentioning
confidence: 99%
“…However, local or systemic treatment is recommended for individuals with complex CL defined as the presence of subcutaneous nodules; area greater than 5 cm; regional adenopathy; lesions on the face, fingers, toes, or genitalia; location or size not amenable to localized treatment; immunocompromised host; previous clinical failure; infection due to a Leishmania species potentially associated with mucosal disease; or diffuse CL. 9,10 In these clinical scenarios, treatment accelerates the healing process and reduces the chances of relapse and dissemination (mucosal or visceral).…”
Section: Discussionmentioning
confidence: 99%
“…There are a variety of atypical cutaneous manifestations, however, including nodular, sporotrichoid, disseminated, psoriasiform, verrucous, zosteriform, eczematous, and/or erysipeloid (Figs. 3 and 4 ) [ 4 •, 22 ]. Other atypical presentations include small satellite lesions outside of the plaque/ulcer (nodular lymphangitis) (Fig.…”
Section: Clinical Symptomsmentioning
confidence: 99%